Predictive Biomarkers for Patient Selection in BTK Inhibitor Therapies
In conclusion, the use of predictive biomarkers is transforming the BTK inhibitors market, enabling more personalized and effective treatment strategies. As research into biomarkers continues, it will further refine patient selection and optimize the therapeutic potential of BTK inhibitors